Navigation Links
Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
Date:8/15/2011

efforts on the clinical development of new therapies for dyslipidemia.  Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.  In March 2011, the Company initiated a pivotal Phase III clinical trial for its lead product candidate, Epanova™, an Omega-3 fatty acid compound in development as a triglyceride-lowering adjunct therapy to diet in patients with very high triglycerides (greater than or equal to 500 mg/dL).  In August, 2011, Omthera initiated a Phase III trial for Epanova in patients with high triglycerides (greater than or equal to 200 mg/dL and less than or equal to 500 mg/dL) currently on statin therapy.  Omthera holds worldwide rights to Epanova under a license from Chrysalis Pharma AG, a privately held Swiss company that is the owner of the product.  For more information, please visit www.omthera.com.Omthera Contacts:Omthera Media Relations:Douglas Carr

Eric GoldmanFinancial Controller

Rx Communications GroupOmthera Pharmaceuticals

917-322-2563908-741-4323

egoldman@rxir.comDCarr@Omthera.com
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
2. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
3. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
4. Omthera Pharmaceuticals, Inc. to Present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference
5. Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
6. Omthera Pharmaceuticals, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference
7. Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
8. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
9. Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
10. K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business
11. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Research and Markets has announced the addition ... report to their offering. ... An ophthalmic diagnostic device is a ... in the human visual pathway. Ophthalmic devices are used ... glaucoma, retinal disorders, conjunctivitis, and dry eyes. ...
(Date:7/25/2014)... July 25, 2014  Semler Scientific, Inc. (Nasdaq: ... risk assessment company that develops patented products that ... chronic diseases, today reported financial results for the ... 2014. "The second quarter of ... Doug Murphy-Chutorian , M.D., chief executive officer ...
(Date:7/25/2014)... , July 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... a corporate update and report second quarter 2014 financial ... Friday, August 1, 2014. That same day, Arena will ... Eastern Time (5:30 a.m. Pacific Time). ... for domestic callers and 914.495.8552 for international callers. Please ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3
... 28, 2011 The Oklahoma Bureau of Narcotics (OBN) ... WBH, the owner/operator of the Energy-from-Waste facility in Tulsa ... state.  Since March 1, 2011, through the Safe Trip ... permanent drug disposal metal containers in police and sheriff ...
... July 28, 2011 Futbol Club (FC) Barcelona, ... Gates Foundation kicked off a three-year partnership today to ... attention to the promise of life-saving vaccines.  Bill Gates, ... with FC Barcelona President Sandro Rosell and Manager Josep ...
Cached Medicine Technology:Narcotics Bureau Partners With Covanta Energy and the City of Tulsa for Safe Prescription Drug Disposal 2Narcotics Bureau Partners With Covanta Energy and the City of Tulsa for Safe Prescription Drug Disposal 3Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 2Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 3
(Date:7/26/2014)... 2014 “BRIC Sinuscopes Market Outlook to ... market. The report provides value, in millions of US ... dollars) within market segments – Rigid Non-Video Sinuscopes. , ... data for each of these market categories, and global ... and news and deals related to the Sinuscopes market ...
(Date:7/26/2014)... Dallas, TX (PRWEB) July 26, 2014 ... sclerosis or encephalomyelitis disseminata, is an inflammatory disease ... in the brain and spinal cord are damaged. ... the nervous system to communicate, resulting in a ... mental, and sometimes psychiatric problems. Multiple sclerosis takes ...
(Date:7/26/2014)... 26, 2014 According to the Metabolic ... is a comprehensive bodybuilding program that helps men lose ... anabolic steroids . The program also instructs men how ... , Vkool reveals in its review that this ... can help men get ripped and jacked at the ...
(Date:7/25/2014)... 26, 2014 Dental Perfection, a Derby ... services including general dentistry, clear braces and much more, ... this year in Derby. The new practice, which is ... Medical Centre in Littleover, Derby. Patients may already pre-register ... The new dental practice, which is headed by Invisalign ...
(Date:7/25/2014)... 26, 2014 According to a ... by Product (vibration monitoring, thermography, ultrasound emission, lubricating ... Component, Application and Geography - Global Forecast to ... health monitoring market is expected to reach $2.50 ... 2020. , Browse 117 market data Tables and ...
Breaking Medicine News(10 mins):Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 3Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 4Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4
... According to a study published in the October issue of ... phyllodes tumors rare breast malignancies accounting for 0.5 to ... more prevalent in Hispanic patients. Population-based estimates indicate that the ... women, with the highest frequencies in Hispanic women. Previous ...
... Whistleblowing incidents can have a serious, long-term impact on ... a responsibility to provide them with the support they ... of the Journal of Clinical Nursing . ... nurses who had been reported by whistleblowers. ...
... cancer survivors in Northern Ireland suffer from physical and ... according to new research from Macmillan Cancer Support and ... its kind in Northern Ireland, also found cancer survivors ... services than the general population. The research highlighted ...
... partnership with the American Society for Radiation Oncology (ASTRO), ... recognized 39 educators with the 2011 Educator of the ... the Year Award to recognize outstanding teachers and mentors ... programs were given the opportunity to select one faculty ...
... By Steven Reinberg HealthDay Reporter , MONDAY, Oct. ... as multivitamins, minerals and folic acid may actually raise the ... new study suggests. Dietary supplements are widely used in ... disease. However, the long-term health consequences of many compounds are ...
... conclusions can be drawn about the effect of recent reforms ... coalition government,s proposals to extend competition, warn experts on ... Skellern at the London School of Economics and Political Science ... of hospital competition on quality of care within the English ...
Cached Medicine News:Health News:Hispanic women have higher incidence of rare breast tumor 2Health News:Greater support is needed to tackle the serious emotional consequences of whistleblowing 2Health News:Greater support is needed to tackle the serious emotional consequences of whistleblowing 3Health News:Almost half of cancer survivors have ill health in later years 2Health News:ARRO honors 39 with Educator of the Year Award 2Health News:Dietary Supplements May Harm Older Women: Study 2Health News:Dietary Supplements May Harm Older Women: Study 3Health News:Experts question merits of extending competition to improve hospital care 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: